EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Leveraging aptamers for targeted protein degradation

Zhihao Yang, Qiuxiang Pang, Jun Zhou, Chenghao Xuan, Songbo Xie

Trends in Pharmacological Sciences · 2023

DOI: 10.1016/j.tips.2023.05.008 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Trends in Pharmacological Sciences, 2023. Verfasst von Zhihao Yang und 4 weiteren Autor:innen. Beteiligte Einrichtung: The Province and Ministry Co-sponsored Collaborative Innovation Center for Medical Epigenetics, Key Laboratory of Immune Microenvironment and Disease…. Hauptthemen laut MEDLINE: Aptamers, Nucleotide, Proteolysis, Proteins. Die Arbeit wurde bisher 50-mal zitiert (Crossref) und nennt 84 Literaturangaben. Gefördert von: National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Targeted protein degradation (TPD) technologies, particularly proteolysis-targeting chimeras (PROTACs), have emerged as a significant advancement in drug discovery. However, several hurdles - such as the difficulty of identifying suitable ligands for traditionally undruggable proteins, poor solubility and impermeability, nonspecific biodistribution, and on-target off-tissue toxicity - present challenges to their clinical applications. Aptamers are promising ligands for broad-ranging molecular recognition. Utilizing aptamers in TPD has shown potential advantages in overcoming these challenges. Here, we provide an overview of recent developments in aptamer-based TPD, emphasizing their potential to achieve targeted delivery and their promise for the spatiotemporal degradation of undruggable proteins. We also discuss the challenges and future directions of aptamer-based TPD with the goal of facilitating their clinical applications.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Aptamers, NucleotideProteolysisProteinsHumansAnimalsDrug Delivery SystemsDrug DiscoveryLigands

Stichwörter der Autor:innen

PROTACaptamerspatiotemporal regulationtargeted deliverytargeted protein degradationundruggable protein

Substanzen

Aptamers, NucleotideProteinsLigands

Autor:innen und Institutionen

  • The Province and Ministry Co-sponsored Collaborative Innovation Center for Medical Epigenetics, Key Laboratory of Immune Microenvironment and Disease (Ministry of Education), Department of Biochemistry and Molecular Bio…
  • School of Life Sciences and Medicine, Shandong University of Technology, Zibo, China.
  • Center for Cell Structure and Function, Shandong Provincial Key Laboratory of Animal Resistance Biology, Collaborative Innovation Center of Cell Biology in Universities of Shandong, College of Life Sciences, Shandong No…
  • School of Life Sciences and Medicine, Shandong University of Technology, Zibo, China; Center for Cell Structure and Function, Shandong Provincial Key Laboratory of Animal Resistance Biology, Collaborative Innovation Cen…

Förderung

  • National Natural Science Foundation of China

Zitieren

APA

Yang, Z., Pang, Q., Zhou, J., Xuan, C., & Xie, S. (2023). Leveraging aptamers for targeted protein degradation. Trends in Pharmacological Sciences. https://doi.org/10.1016/j.tips.2023.05.008

Vancouver

Yang Z, Pang Q, Zhou J, Xuan C, Xie S. Leveraging aptamers for targeted protein degradation. Trends in Pharmacological Sciences. 2023. doi:10.1016/j.tips.2023.05.008

BibTeX
@article{Yang2023,
  author = {Yang, Zhihao and Pang, Qiuxiang and Zhou, Jun and Xuan, Chenghao and Xie, Songbo},
  title = {Leveraging aptamers for targeted protein degradation},
  journal = {Trends in Pharmacological Sciences},
  year = {2023},
  doi = {10.1016/j.tips.2023.05.008}
}
Kostenlos starten →